Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia

NCT02015208 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Ruxolitinib

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]